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The  noticeable  phenomenon  of  an  increased  frequency  of  immune-inﬂammatory  disorders,
in the  industrialized  world,  has  led  to the  implication  of  parasitic  infections  in  the  patho-
physiology  of  these  diseases.  Most  of  the  studies  investigated  the  infection  connection  to
allergy  have  centered  on  helminthes.  Parasitic  helminthes  are  a group  of  metazoans  that
are evolutionary  diverse,  yet converge  to  evolve  common  modes  of immunomodulation.
Helminth  immunoregulation  is  mainly  mediated  by  a regulatory  response  including  Treg
and Breg  cells  with  alternatively-activated  macrophages.  There  is increasing  evidence  for  a
causal  relationship  between  helminth  infection  and allergic  hyporesponsiveness,  however,
conﬂicting  data  are  still generating.  The  helminth  immunoregulation  seems  to  be  species-
speciﬁc  and  phase-speciﬁc.  It depends  on  the stage  of  the  clinical  disease  which  correlates
with a corresponding  parasitic  stage  (egg,  larva  or mature  adult).  Here,  we review  the  cel-
lular and  molecular  mechanisms  utilized  by  helminthes  to manipulate  the  immune  system
and  the  consequent  bystander  immunomodulatory  responses  toward  environmental  aller-
gens.  We  especially  focus  on  parasitic  species  and  molecules  involved  in  the modulation  of
allergic  disorders  and  summarize  the  experimental  and  clinical  trials  using  them  as  ther-
apeutic agents.  We  also  discuss  the  potentials  and  obstacles,  for  helminthes  and/or  their
derived molecules,  to emerge  as  novel  therapeutic  modalities.
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1. Introduction
The accumulated information investigating the asso-
ciation of parasitic infections with allergic disorders,
is mostly conﬂicting. Genetic, environmental, life cycle-
phase-speciﬁc and niche-speciﬁc factors intensify the
complexity of the association. This relationship has not only
an epidemiological perspective but interesting immuno-
logical and clinical aspects as well. There is an obvious
similarity between the inﬂammation caused by the aller-
gic immune responses to many environmental allergens
and that developed in response to some helminth antigens
[1]. Immune responses to both are characterized by a pre-
dominant T helper type 2 (Th2) activation with consequent
upregulation of IL-4, IL-5 and IL-13. This is usually accom-
panied by tissue eosinophilia, over-secretion of mucus and
upregulation of IgE antibody [2,3]. Most of the studies
investigated the infection connection to allergy have cen-
tered on helminths [4] noted that their data have mostly
offered a solid evidence for a protective contribution of
helminth infections.
Parasitic helminthes are a group of metazoans with
a long but diverse evolutionary history. The helminthes
that infect humans ﬁt in two taxonomic phyla, platy-
helminths (ﬂatworms) and nematodes (roundworms).
Platyhelminths consist of the trematodes or ﬂukes (leaf-
like worms) and the cestodes (tapeworms). Nematodes
include the majority of helminthes that are prevalent in
humans. These parasites that have independently evolved,
to attain different invasion methods and different host
niches, exhibit a striking convergence of their modes of
immunomodulation [5]. In their way to evade host immune
mechanisms to establish their existence in safe niches,
parasites adopt immunosuppressive pathways that might
also repress bystander reactions to allergens and self-
antigens [6].
What was considered as a general immunosuppres-
sion induced by helminthes, is currently acknowledged as
an immunomodulation, a conserved phenomenon across
species, classes to phyla [7]. Helminth immunomodulation
has two predominant characteristics; ﬁrst is the induc-
tion of a Th2 response with a speciﬁc cytokine paradigm
comprising IL-4, IL-5 and IL-13 together with IgE anti-
body and recruitment of eosinophils and mastocytes;
secondly, is the activation of a regulatory response that
include anti-inﬂammatory cytokines namely IL-10 and
TGF- together with regulatory T-(Treg) and B-(Breg) cells
and alternatively-activated macrophages [8].
A comprehensive analysis of the parasite biology and
the predominant immune responses, in both allergy and
helminth exposure, is a prerequisite for better understand-
and discusses the explanations for these in the literature.
It also provides an insight on the protective pathways
against allergic disorders conferred by parasites with dis-
tinct emphasis on helminth infections. It is also concerned
with the therapeutic potentials of live-helminth infection
as well as helminth-derived molecules and summarizes
related clinical and experimental trials in the literature.
1.1. Parasites, allergic disorders and the “hygiene
hypothesis”
During the twentieth century, there were an unusu-
ally noticeable phenomenon of an increased frequency of
several inﬂammatory diseases in the developed part of
the world. These included allergic diseases and autoim-
mune disorders such as diabetes, multiple sclerosis (MS),
rheumatoid arthritis (RA), allergic diseases and inﬂamma-
tory bowel disease (IBD) [9,10]. The genetic background
was  not an enough answer to the compelling question of
why  such increases have been so rapid. Environmental fac-
tors and different susceptibility to triggering agents such
as microbial infections were suggested to explain the phe-
nomenon. Thus a classic model of gene–environment inter-
action, was  proposed to justify the recent nature of these
increases. The model suggested a major underlying ground
for environmental factors with genetic factors just deter-
mine who  is susceptible to clinical disease due to these
ecological limiting factors [11]. “Hygiene hypothesis,” was
ﬁrst suggested by Strachan, who  realized a negative asso-
ciation between hay fever and the number of older siblings
in a meta-analysis study included around 17,000 children
[12]. This hypothesis was  later extended to include autoim-
mune disorders [13]. Many studies have indicated high
rate of autoinﬂammatory disorders, expressed by increased
prevalence of autoimmune diseases and allergies in devel-
oped countries [14,15]. It is believed that the growing rate
of urbanization, in the industrialized countries, have cre-
ated an urban environment depleted from many organisms
co-evolved with mammals, and impose a co-evolutionary
pressure that is ultimately was able to set up a “nor-
mal” of immune programming to combat infectious agents.
Higher quality of life and reﬁned standards of living in the
developed world led to a decrease in the infections bur-
den. The limited exposure to microbial infections especially
during childhood may  have led to failure of the immune
system to program itself to face these infections. This
eventually result in an off-balanced, dysregulated immune
responses [16]. The occurrence as well as the severity of
allergic disorders are not limited to environmental fac-
tors encountered during childhood and adulthood [17,18].
There is compelling proof that the vulnerability to allergying of this multifaceted relationship. This review explores
the epidemiology, biology and immunology of the com-
plex relationship between allergy and parasitic infection.
The paper also tackles the discrepancies in this relationshipand the qualitative divergence of immune reactions in
response to homologous and heterologous antigens might
be concluded during the uterine life or soon after. Prena-
tal programming according to maternal signals has been
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eported to inﬂuence the immune system maturation of
he offsprings [19,20]. Established helminth infection dur-
ng pregnancy has been suggested to distinctly alter the
llergic phenotype of born children stretching from protec-
ion to exacerbation [21]. Children born and grow in a rural
reas, exposed to a diverse spectrum of infectious agents,
evelop asthma less frequently than those from urban dis-
ricts [22]. Additionally, children born to mothers exposed
o farm animals and consumed raw milk, during pregnancy,
ave lesser chance to get allergic disorders [18]. Children
orn to mothers infected with schistosomes and treated
ith praziquantel while pregnant, demonstrated a higher
requency of eczema, indicating allergy-preventing effects
f maternal schistosomiasis [23].
One example that illustrates the hygiene hypothesis
s malaria’s prevalence, which is in reverse correlation to
utoimmune diseases in Sardinia. Compelling proofs link
he disappearance of malaria, due to human’s eradication
rogram, with the increased frequency of multiple sclero-
is (MS) [24,25]. MS  is extremely rare in regions with a 10%
r more prevalence of T. trichiura and shows a sharp rise
n regions with lower prevalence [26]. Moreover, the posi-
ive association of infections to autoimmune diseases was
lso established in the Finland’s part of Karelian region with
n extremely high incidence of autoimmunty and allergic
isorders, while their prevalence in the Russian’s side, with
igher incidence of infections, is far lower [27,28]. All these
eports are entirely correlative, circumstantial evidence
ithout a direct proof of a link. However, it has been shown
hat MS  patients, who later acquired helminthic infections,
eveloped a remarkably reduced disease progression. The
educed disease activity was marked by higher levels of cir-
ulating Treg cells that release IL-10 and TGF- in reply to a
ertain myelin peptide [29]. A regulatory B cells population
hat secretes IL-10 was also upregulated in these patients.
elapses have reported to occur rapidly on helminth erad-
cation [30].
. Immunomodulation by parasites
Many microbes are implicated as possible immunomod-
lators especially those that have a long co-evolutionary
ssociation with humans and are transmitted mainly by
ecal–oral route or soil transmitted [12] Most of the atten-
ion was centered on the role of helminth infections in
ipping the balance to retain regulated immune responses
nd reverse their deleterious consequences to counteract
llergies [31,32].
Helminths are masters of immune modulation; a pos-
ible requirement to establish chronic infections. In order
o combat the efforts of the host to expel them and
o create an environment that is permissive for long-
erm parasitism, it is essential for parasites to modulate
ost immune responses that endanger their existence.
his is in part achieved by enhancing certain immune
ell populations especially regulatory T (Treg) [33], TGF-
 and IL-10-producing B cells [34,35], and enhance also
he immune-dampening properties of helminth-derived
ntigens [36]. Owing to the resultant immunosuppressive
ffects that extend to bystander antigens, such as aller-
ens, helminthes have a signiﬁcant contribute to the lowd Ultrastructure 3 (2015) 53–61 55
prevalence of allergic diseases in helminth endemic areas
[37].
From a viewpoint of translational biology, clariﬁcation
of immune reactions in response to helminth infection
might be useful in mitigating bystander inﬂammatory
reactions. An accumulated literature has indicated that
helminth infections confer, at least, a partial protection
against a diverse spectrum of auto-inﬂammatory diseases.
This protective action has been mediated through either
a direct immunomodulatory effect exerted by the excre-
tory/secretory (ES) antigens of the parasite or via the
transfer of anti-helminth immune molecules to a host [38].
Helminth infections have been reported to reduce the
susceptibility to autoimmune and/or allergic disorders. A
negative association was  recognized between autoimmune
liver diseases and infestation with Strongyloides stercoralis
[39]. Infection with helminthes, especially Schistosoma sp.,
conferred a hyporesponsive effect on the atopic reaction
in skin prick tests [40,41]. Moreover, the protective effects
of helminth infections have been also demonstrated in a S.
mansoni-worm-only infection in animal models of airway
hypersensitivity [42]. While helminth infection confers an
anti-allergic effect, de-worming could lead to enhanced
sensitization. Eradication of certain helminths was enough
to boost atopic skin sensitization in Venezuela [43], in
Gabon [44], and in Vietnam [45].
2.1. Modulation of innate immune cells
Processing of an antigen and its presentation to T cells,
by antigen presenting cells, typically dendritic cell (DC), is
the ﬁrst reaction of the immune system to an infectious
agent. This response is marked by an upregulation of sur-
face ligands expression that, in turn, with some soluble
mediators activate T cells that are speciﬁc to this speciﬁc
antigen [5]. This interaction might determine the immune
response quality directing it to either Th1 or Th2 paradigm
[46], or alternatively toward a Treg regulatory pathway
[47].
Parasite antigens could manipulate this process, inhib-
iting the proinﬂammatory Th1/17 response or directing
DC phenotype toward an anergic or tolerogenic pattern.
DCs, cultured with soluble egg antigen (SEA) of S. mansoni,
are able to initiate IL-4-independent Th2 response without
the process of classical ligand expression [48]. Likewise,
Nippostronglyus brasiliensis adult [49] or larval [50] ES anti-
gens provoke a Th2 response independent from IL-4-, IL-5-
or B cell [51]. Transfer of DCs, sensitized with these anti-
gens, was able to induce the same response in vivo [52].
Dendritic cells, sensitized with Fasciola hepatica ES anti-
gens, can induce in vitro T cells differentiation toward a
Th2 phenotype [53]. Thus an array of antigens from differ-
ent parasites to consume a common alternative pathway
of IL-4-independent activation of macrophages and DC
to provoke an anti-inﬂammatory Th2 immune response
[54,55].
Basophils are essential innate effector cells, which have
a role in the defense against helminths and a proinﬂamma-
tory action during allergic inﬂammation. Basophils are also
effective modulator of Th2 response during helminthic
infection and allergen sensitization [56]. Some studies
scopy an56 M.A. Aﬁﬁ et al. / Journal of Micro
[57,58] suggest that basophils might act, in these situation
as APC inducing Th2 responses in the absence of DCs.
Basophils are able of cross-linking surface-bound IgE to
secrete IL-4 in a signiﬁcant manner as a consequence
of a dominant Th2 paradigm initiated in response to
circulating parasitic antigen-speciﬁc IgE complex. Some
helminthic antigens could activate basophil responses
to mediate parasite and/or host survival. Schistosomes
are able to induce basophil production of IL-4 without
prior IgE response to schistosome antigens [5]. However,
basophils develop an IL-10-dependent hyporesponsive
pattern to parasitic antigens, in certain chronic infections
like S. mansoni or Litomosoides sigmodontis, a ﬁnding helps
elucidate the possible mechanisms by which helminths
might suppress allergy and may  reveal how helminths
modulate other disorders [59].
Concerning eosinophils, similar paradoxical responses
were observed. Although still considered as tissue-
damage and pathology promoters, eosinophils also have
immunoregulatory functions that may  inﬂuence the out-
come of infection [60]. Following helminth infection there
is a remarkable rise of eosinophil counts in the blood
that soon migrates to the infection site where degranula-
tion occurs. Peak eosinophilia levels coincide with larval
migration and gradually decrease when larvae develop
into mature adults [61]. Eosinophils seem to communicate
with virtually all immune cells and are involved in a wide
range of anti-helminthic actions. They have a direct killing
effect on Strongyloides stercoralis [62] and have an effect
on Nocardia brasiliensis expulsion [63]. Eosinophils are also
implicated in tissue damage during some ﬁlarial infection
such as Onchocerca volvulus [64,65], Wuchereria bancrofti
[66] and are active components in granuloma formation
pathognomonic of schistosome infection [67]. On the other
hand, helminthes have a manipulative ability exerting
their trickery in attracting eosinophils through chemotac-
tic molecules to secure their endurance, or through evasion
pathways exploited to avoid eosinophil-mediated anti-
helminth toxicity [60].
While several helminth ES antigens induce eosinophilia,
helminth infections, in murine models of asthma, result in
reduced eosinophils. Some parasitic products directly sup-
press eosinophil responses such as H. polygyrus ES (HES)
antigens that suppress eosinophilia in allergen-sensitized
animal models [68]. N. americanus ES products, having neu-
trophil chemotactic actions, may  suppress the recruitment
of eosinophils, that are possibly damaging, while promot-
ing that of ineffectual neutrophils [69,70].
2.2. Modulation of adaptive immune response
The allergic reaction is a complex process inﬂuenced
by numerous effectors and marked by a Th2-type hyper-
responsiveness to allergens that may  result in severe
inﬂammation in certain target tissues including the lung in
patients with asthma [71]. A signiﬁcant pro-inﬂammatory
role of the Th17 [72] and Th9 has been also reported [73]
and a similar Th1 role was mainly linked to severe asthma
[74]. Throughout the allergic response, certain cytokines
such as tumor necrosis factor alpha (TNFA-) and IL-
13, that signiﬁcantly modulate the anti-helminth immuned Ultrastructure 3 (2015) 53–61
responses [75,76], are additionally stimulated, aggravating
the inﬂammatory actions, of the IgE-mast cell-mediated on
the bronchial epithelium and smooth muscle [77]. Simi-
lar roles have been also expressed by IL-17A [78]. The Th2
cells, activated by helminthes, may  also combat allergic
responses possibly by inducing regulatory T cells which in
turn, suppress both Th1 and Th2 arms of immunity [79].
Several studies have tackled the immunomodulatory
effects of parasitic antigens on adaptive immune reactions
coordinated by CD4+ T cells. These modulatory pathways
have been mostly studied in animal murine models. A
helminth that was deeply studied in murine models of
IBD, is the intestinal nematode; Heligmosomoide polygyrus.
It exercises immunoregulatory effects through three main
mechanisms; modulation of intestinal DCs maturation
[80]; direct induction of Treg proliferation [81] and mod-
ulation of the intestinal microbiome [82]; other pathways
might include stimulation of reg B cells [83], modulation of
the Treg/Th17 ratio in the intestine [84] and induction of
regulatory macrophages [85].
Altering DC reactive patterns is a main indirect
immunomodulatory pathway adopted by parasites. T. spi-
ralis and E. multilocularis ES antigens, in vitro, induce a
switch of DCs toward provoking Th2 and Foxp3+ Treg
responses [86–88]. Likewise, DCs co-cultured with -1 S.
mansoni SEA, initiate Foxp3+ Treg response, by stimula-
tion of TGF- and retinoic acid-activating enzymes [89].
HES antigen-sensitized DCs result in a T cells suppressive
phenotype inhibiting IFN- and IL-4 while upregulat-
ing IL-10 [90]. HES products can directly activate Foxp3
expression in naïve T cells without prior DCs sensitization
[81]. Excretory/secretory antigens of Teladorsagia circum-
cincta, a related nematode, induce a similar regulatory
response. Distinctly, Spirometra mansoni ES antigens have
been reported to, in vitro, boost the Tregs suppressive
action [91].
2.3. Helminths as disease stimulators
While most studies indicate a protective downregula-
tory effect of helminth infection on allergic disorders, a
general rule cannot be concluded. A great deal of cau-
tion should be considered not to overstretch the generated
data in order to get general conclusions ignoring many
fundamental variables that are assumed to shape the asso-
ciation of helminth infection to allergic disorders. Some
studies have reported a link between Ascaris infection and
higher incidence of asthma [92], indicating an inﬂuenc-
ing role of the helminth species. However, the role model
for a helminth provokating allergy, is anisakiasis which
was  reported to provoke asthma, urticaria, and anaphy-
laxis [93]. In addition, allergy related to the migration of
Strongyloides spp. is commonly noticed in endemic regions
[94]. Moreover, Toxocara spp., for which man  is not a natu-
ral host, has been also reported to induce allergic disorders
[95].
The timing as well as the course of infection are proba-
bly inﬂuence the helminth/allergy relationship. Offspring
from schistosome-infected mothers that were mated in
the chronic phase of infection with dominant maternal
TH2 immune phase, were more prone and developed
copy an
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ggravated allergic airway inﬂammation [21]. Early and/or
ong-lasting infections protect against allergies, while late
nd/or short-lived infections aggravate allergic symptoms
31]. Interestingly, low-intensity helminth infections are
ikely exacerbate allergic disorders in contrast to heavy
nfection [96]. Moreover, travelers to endemic regions who
appen to get schistosomiasis, develop severe allergic lung
ymptoms [97]. The helminth ability to modulate host
mmune responses may  be in part controlled by host genet-
cs. Genetically susceptible individuals are more at risk of
eveloping allergy in response to helminth infection [98].
Experimental infections, of murine models, conﬁrm
his paradoxical helminth/allergy relationship. Experimen-
al infection with Hymenolepis diminuta, a cestode, of
ice with oxazolone-induced colitis, led to a substantial
ncrease in the pathology [99]. Likewise, infection with
aenia crassiceps has led to cardiomyopathy [100] and
mpliﬁcation of liver pathology caused by carbon tetra-
hloride [101]. Furthermore, mice infected with the latter
arasite were more at risk to infection with Leishmania
ajor and L. mexicana [102]. In the same context, concur-
ent H. polygyrus infection has been reported to enhance
he colonic inﬂammation induced by a bacterial infection
ith Citrobacter rodentium [103].
. Helminth therapy
The principle that helminths could be therapeutic
ia induction of immunoregulation has initiated enor-
ous research efforts to explore the molecular pathways
nvolved to come out with an array of therapeutic
olecules instead of using the parasites themselves in ther-
peutic regimens.
.1. Live-infection therapy
The immunosuppression of human pathology during
arasitic infections has been comprehensively studied
104,105], and helminth therapy is unofﬁcially available
5]. Currently, clinical trials (phase III) are underway for
 new drug called “Trichuris Suis Ova (TSO)” utilizing T. suis
gg as therapeutic agent [106].
Hypothetically, helminth therapy is reasonably
traightforward. Simply, identify a candidate group of
atients and a suitable helminth species, execute required
uality control and studies for dose-ranging, then infect
nd let the natural course of host-parasite interaction pro-
eeds. Undoubtedly, the choice of therapeutic helminth is
f extreme signiﬁcance. The use of a human parasite is not
dvised or a great caution must be taken if to be utilized
38]. Several helminth species, that are likely suitable
or controlled therapeutic clinical trials on humans, have
een identiﬁed. Generally, they are either natural human
arasites that are known to exhibit insigniﬁcant virulence
r animal parasitic species that are unable to accomplish
heir life cycles in humans; nevertheless, they are can
timulate an immune response similar to that evoked by
heir close relatives of human parasites [107].
Several reports have stated negative associations
etween intensity of worm load, and allergic sensitization
o common allergens [108–110]. More notably, the riskd Ultrastructure 3 (2015) 53–61 57
of allergic airway spasm was  reduced in people with
hookworm infection; N. americanus [111]. Patients with
hydatid disease, produced by the larva of a dog cestode;
Ecchinococcus granulosus,  normally show a prevalent
Th2 paradigm and IgE elevation [112]. Normally Th2
response and IgE are responsible of higher risk of asth-
matic responses [96]; thus, infection with E. granulosus
might enhance the airway allergic response. Nevertheless,
no reports indicate a higher risk of allergic disease in E.
granulosus-endemic areas. Recently, E. granulosus infection
markedly mitigates allergic airway inﬂammation probably
by upregulating IL-10 and reducing IL-5 and IL-17A [113].
While schistosomiasis is predominantly associated with
a Th2 response [114], schistosome infections improve the
clinical picture of atopic disorders in humans [35]. More-
over, residents in endemic regions of schistosomiasis had
asthma less frequent than those inhabiting schistosomes-
free zones [115]. Pin-worm infection was  reported to have
a protective effect against asthma and allergic rhinitis in
young children resulting in a milder clinical presentations
of asthma [40]. Similarly, de-worming of children in
Vietnam, Venezuela or Gabon [32,43,44] for 12 months
or more, all result in increased skin sensitization and
enhancement of prick test reactions.
The therapeutic immunoregulatory effect of helminths
is ﬁrst founded for allergic disorders [116]. Clinical trials
have mostly been carried out using the Trichuris suis, a pig
whipworm, that infrequently infects humans, and Necator
americanus, a hookworm that naturally parasitizes humans
[107]. In the early 2000s, Trichuris suis was  suggested to be
a safe and effective therapeutic candidate for inﬂammatory
bowel disease (IBD) [117]. A single dose of T. suis ova was
used to treat Crohn’s disease patients. Up to 7500 ova per
dose was well tolerated and did not result in side effects
even with long-term treatment [118]. Further use of T. suis
eggs showed encouraging therapeutic effects on MS  [119]
and or on some food allergies [105].
Hypothetical suggestions were also made for possible
use of T. suis ova in autism spectrum disorders therapy
[120]. Furthermore, the effect of therapy with helminths
on type I diabetes or rheumatoid disease has also been
investigated [121,122].
However, the transformation of helminth therapy into
standard medical practice confronts serious challenges.
Genuine practical and ethical matters might represent
serious obstacles to live infection therapy. First, live par-
asite resources would not cover the expected increasing
demands; the frequency of parasitic infections is declining
while there is a steep rise of allergic disorders. Secondly,
many ambiguous factors determine the outcome of infec-
tion [123]. Genetic and environmental factors enforce
an individual or community level of outcome prediction,
therefore, expectation of a single pattern, of parasitic
disease outcome, is not practical. Live helminth treatment
has another disadvantage of being largely given on random
basis with no deﬁned doses or well-known mechanisms
of action [5]. Most reports are based on a small number
of patients and can be considered only preliminary. The
reported data have been relatively recent and thereby the
deleterious outcomes of long-term or repeated helminthic
infections are basically unpredictable [38]. Therefore, the
scopy an58 M.A. Aﬁﬁ et al. / Journal of Micro
characterization of parasite-derived molecules as novel
immunomodulators for therapeutic purposes, are urgently
needed [5].
3.2. Helminth-derived molecules therapy
Molecular characterization of host pathways possibly
consumed by parasites as well as parasitic motifs that are
involved in mitigating immunopathology, must initially be
distinguished. Naturally extracted helminths products or
synthetic analogs that exhibit immunomodulatory actions
can be considered for novel therapeutic approaches. Non-
living parasite-derived molecules might be the future
therapeutic candidates of many chronic inﬂammatory dis-
orders.
Helminths are metazoans with multicellular nature.
Therefore, they could represent an unlimited source
of many immunomodulatory molecules. Molecular
immunomodulatory helminth products belong to diverse
biochemical classes; carbohydrates, proteins, and lipids,
have been characterized. A broad range of parasite-
derived molecules of several parasite species has been
tested. The nature of these molecules range from whole
parasite extracts, through fractionated parasitic products,
and secretory materials, to recombinant proteins and
synthetic glycans [34]. Lacto-Nfucopentaose III (LNFP
III), oligosaccharide from schistosome ova, was showed
to induce IL-10 production and stimulate macrophages
[124]. A schsitosome-egg-derived chemokine-binding
protein (CBP) demonstrated the ability to impede the
neutrophil recruitment to inﬂammatory sites [125]. An
antioxidant protein (Peroxiredoxin) from S. mansoni [126]
and F. hepatica [127], alternatively stimulate macrophages.
Peroxiredoxin is also engaged in the induction of Th2
responses. Another signiﬁcant molecule, that is also
derived from schistosome ova, is the IL-4-inducing prin-
ciple of S. mansoni eggs (IPSE) that is able to induce
basophil production of IL-4 via an IgE-dependent and
antigen-independent pathway [128].
These therapeutic classes have been screened at dif-
ferent levels of testing from in vitro testing of a single
molecule on an individual immune cell type through to
complex animal models of immune-inﬂammatory dis-
eases [5]. Some helminth-induced immune byproducts,
especially the cytokines, could have protective respiratory
and anti-allergic effects, and may  therefore become use-
ful as therapeutic modalities for many allergic disorders.
Interestingly, it was identiﬁed that in helminth-infected
mothers, the transfer of maternally derived IFN- dur-
ing the acute phase of infection to the fetus rather than
helminth antigens is essential for the progeny’s protective
immune phenotype [21]. With further study, identiﬁcation
of additional helminth-induced immune substances could
open the way to novel approaches for immune manip-
ulation. Nevertheless, the potential, of helminth-derived
molecules, as a basis of novel medications has not been
yet accomplished. This probably indicates the complex-
ity of extracting reﬁned molecules, of therapeutic quality,
from little crude parasitic material that is practically avail-
able. Technical issues, concerning the puriﬁcation of certain
molecules such as lipids and glycans, are also potentiald Ultrastructure 3 (2015) 53–61
obstacles. However, the progress in protein puriﬁcation,
sequencing and transcriptomics indicates that helminth-
derived immunoregulatory molecules might emerge as a
promising array of medications [38].
4. Conclusion
The anti-parasite immune responses, while usually fail
to eradicate helminths, yet, they might beneﬁt the host
by suppressing deleterious allergic reactions. Several stud-
ies demonstrate a protective action of helminth infection
against allergic diseases, however, a causal association
between helminth infections and allergy remains to be
proven. The helminth-mediated immunomodulation of
allergy is probably mediated by a regulatory response
that includes anti-inﬂammatory cytokines, alternatively-
activated macrophages as well as regulatory Treg and
Breg cells. The timing of infection might have a deter-
mining effect on the development of allergic responses.
Early exposures, in utero or soon after, to helminthes could
favorably program the immune system to express efﬁ-
cient anti-allergic responses. The therapeutic effect of live
helminth infections seems to be not only species-speciﬁc
but also phase-speciﬁc depending on the clinical stage of
the disease (acute or chronic) which correlates with a cor-
responding life-cycle stage of the parasite (egg, larva or
mature adult). Eggs of T. suis and larvae of N. americanus
are the most used parasitic stages in human clinical tri-
als. However, live-infection therapy faces real practical
and ethical obstacles to evolve as a standard therapeutic
modality. Future research should focus on comprehensive
characterization of helminth-derived molecules that have
a potential therapeutic utility.
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